• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甘油三酯-葡萄糖指数在非酒精性脂肪性肝病中的诊断效用:一项针对瘦人群体的横断面研究

Diagnostic Utility of Triglyceride-Glucose Index in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study on Lean Population.

作者信息

Han Tuo, Li Ying, Xiao Jing, Gong Hong, Deng Fuxue, Jiang Wei, Wang Congxia, Chen Fangyao, Zhang Chunyan, Deng Jie, Zhang Yan

机构信息

Department of Cardiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, People's Republic of China.

Department of Health Management, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, People's Republic of China.

出版信息

Diabetes Metab Syndr Obes. 2024 Sep 21;17:3547-3556. doi: 10.2147/DMSO.S469398. eCollection 2024.

DOI:10.2147/DMSO.S469398
PMID:39328264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11424687/
Abstract

BACKGROUND

Approximately 10-20% of individuals with non-alcoholic fatty liver disease (NAFLD) are lean, and the underlying pathophysiology is not yet understood. This study aims to explore the characteristics and the diagnostic value of triglyceride-glucose index (TyG) in early diagnosis of lean NAFLD.

METHODS

99 patients with lean NAFLD and 1891 healthy controls were included in the health examination. The characteristics were compared between groups. Restricted cubic spline was utilized to analyze the relationship between TyG index and the risk of lean NAFLD. Logistic regression and receiver operating curve (ROC) were applied to explore the diagnostic value of TyG index for lean NAFLD.

RESULTS

Overall, 99 (4.97%) patients had lean NAFLD. Patients with lean NAFLD have significant abnormal glycolipid metabolism and higher TyG index. Restriction cube spline analysis showed a significant dose-response relationship between the TyG index and risk of lean NAFLD. After adjusting for confounders, the relationship remained and the risk of developing lean NAFLD increased 2.99 times for per unit increase of TyG index (95% CI: 1.94, 4.67, <0.001). The areas under the ROC of the TyG index for lean NAFLD detection were 0.851 (0.815 to 0.886).

CONCLUSION

The TyG index is positively associated with the risk of developing lean NAFLD and could be a useful marker for early diagnosis of lean NAFLD.

摘要

背景

大约10%-20%的非酒精性脂肪性肝病(NAFLD)患者体型消瘦,其潜在的病理生理学机制尚不清楚。本研究旨在探讨甘油三酯-葡萄糖指数(TyG)在消瘦型NAFLD早期诊断中的特征及诊断价值。

方法

选取99例消瘦型NAFLD患者和1891例健康对照者进行健康体检。比较两组之间的特征。采用限制立方样条分析TyG指数与消瘦型NAFLD风险之间的关系。应用逻辑回归和受试者工作特征曲线(ROC)探讨TyG指数对消瘦型NAFLD的诊断价值。

结果

总体而言,99例(4.97%)患者患有消瘦型NAFLD。消瘦型NAFLD患者存在明显的糖脂代谢异常且TyG指数较高。限制立方样条分析显示TyG指数与消瘦型NAFLD风险之间存在显著的剂量反应关系。在调整混杂因素后,这种关系仍然存在,TyG指数每增加一个单位,发生消瘦型NAFLD的风险增加2.99倍(95%CI:1.94,4.67,<0.001)。TyG指数检测消瘦型NAFLD的ROC曲线下面积为0.851(0.815至0.886)。

结论

TyG指数与消瘦型NAFLD的发生风险呈正相关,可能是消瘦型NAFLD早期诊断的有用标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e366/11424687/12bb2106f2fa/DMSO-17-3547-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e366/11424687/074fadb1c640/DMSO-17-3547-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e366/11424687/c00f7a18057b/DMSO-17-3547-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e366/11424687/12bb2106f2fa/DMSO-17-3547-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e366/11424687/074fadb1c640/DMSO-17-3547-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e366/11424687/c00f7a18057b/DMSO-17-3547-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e366/11424687/12bb2106f2fa/DMSO-17-3547-g0003.jpg

相似文献

1
Diagnostic Utility of Triglyceride-Glucose Index in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study on Lean Population.甘油三酯-葡萄糖指数在非酒精性脂肪性肝病中的诊断效用:一项针对瘦人群体的横断面研究
Diabetes Metab Syndr Obes. 2024 Sep 21;17:3547-3556. doi: 10.2147/DMSO.S469398. eCollection 2024.
2
[Triglyceride-glucose index in non-obese individuals: its association with and predictive value for non-alcoholic fatty liver disease].非肥胖个体的甘油三酯-葡萄糖指数:其与非酒精性脂肪性肝病的关联及预测价值
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Jul 20;44(7):1266-1271. doi: 10.12122/j.issn.1673-4254.2024.07.06.
3
Association between the Triglyceride-Glucose Index and Non-Alcoholic Fatty Liver Disease in patients with Atrial Fibrillation.甘油三酯-葡萄糖指数与房颤患者非酒精性脂肪肝的相关性。
Eur J Med Res. 2023 Sep 19;28(1):355. doi: 10.1186/s40001-023-01188-2.
4
Triglyceride-glucose index and combined indicators: effective indicators for screening NAFLD in snoring patients.甘油三酯-葡萄糖指数和联合指标:打鼾患者非酒精性脂肪性肝病筛查的有效指标。
BMC Pulm Med. 2024 Jul 24;24(1):359. doi: 10.1186/s12890-024-03166-8.
5
Association between TyG index trajectory and new-onset lean NAFLD: a longitudinal study.体重指数轨迹与新发病例非酒精性脂肪肝瘦体型的相关性:一项纵向研究。
Front Endocrinol (Lausanne). 2024 Feb 27;15:1321922. doi: 10.3389/fendo.2024.1321922. eCollection 2024.
6
[Relationship between triglyceride-glucose index and non-alcoholic fatty liver disease].甘油三酯-葡萄糖指数与非酒精性脂肪性肝病的关系
Zhonghua Gan Zang Bing Za Zhi. 2021 May 20;29(5):451-455. doi: 10.3760/cma.j.cn501113-20200615-00322.
7
Triglyceride-Glucose Index is Significantly Associated with the Risk of Hyperuricemia in Patients with Nonalcoholic Fatty Liver Disease.甘油三酯-葡萄糖指数与非酒精性脂肪性肝病患者高尿酸血症风险显著相关。
Diabetes Metab Syndr Obes. 2023 May 8;16:1323-1334. doi: 10.2147/DMSO.S408075. eCollection 2023.
8
The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population.甘油三酯-血糖-体重指数:一种在普通日本人群中识别非酒精性脂肪肝的非侵入性指标。
J Transl Med. 2022 Sep 5;20(1):398. doi: 10.1186/s12967-022-03611-4.
9
Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.非肥胖血脂正常人群中甘油三酯-葡萄糖-体重指数与非酒精性脂肪肝的相关性:基于前瞻性队列研究的二次分析。
Lipids Health Dis. 2020 Oct 28;19(1):229. doi: 10.1186/s12944-020-01409-1.
10
A combined analysis of TyG index, SII index, and SIRI index: positive association with CHD risk and coronary atherosclerosis severity in patients with NAFLD.联合分析 TyG 指数、SII 指数和 SIRI 指数:与 NAFLD 患者的 CHD 风险和冠状动脉粥样硬化严重程度呈正相关。
Front Endocrinol (Lausanne). 2024 Jan 8;14:1281839. doi: 10.3389/fendo.2023.1281839. eCollection 2023.

引用本文的文献

1
Comparison of the predictive value of TyG index and METS-IR for OSA combined with NAFLD: a retrospective observational study based on a physical examination population.TyG指数和METS-IR对阻塞性睡眠呼吸暂停合并非酒精性脂肪性肝病的预测价值比较:一项基于体检人群的回顾性观察研究
BMC Gastroenterol. 2025 Apr 21;25(1):279. doi: 10.1186/s12876-025-03856-5.

本文引用的文献

1
Diagnostic value of triglyceride-glucose index and related parameters in metabolism-associated fatty liver disease in a Chinese population: a cross-sectional study.中国人代谢相关脂肪性肝病中甘油三酯-葡萄糖指数及相关参数的诊断价值:一项横断面研究。
BMJ Open. 2023 Sep 29;13(9):e075413. doi: 10.1136/bmjopen-2023-075413.
2
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.超重和肥胖人群中非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球患病率:一项系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2023 Jan;8(1):20-30. doi: 10.1016/S2468-1253(22)00317-X. Epub 2022 Nov 16.
3
Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study.
甘油三酯-葡萄糖指数在预测早发冠心病患者不良心血管事件中的作用:一项回顾性队列研究。
Cardiovasc Diabetol. 2022 Jul 29;21(1):142. doi: 10.1186/s12933-022-01576-8.
4
Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis.非肥胖性非酒精性脂肪性肝病(NAFLD)患者与非非肥胖性 NAFLD 患者代谢功能障碍负担的比较:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2023 Jul;21(7):1750-1760.e12. doi: 10.1016/j.cgh.2022.06.029. Epub 2022 Jul 19.
5
AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.AGA 临床实践更新:瘦个体中非酒精性脂肪性肝病的诊断和管理:专家评论。
Gastroenterology. 2022 Sep;163(3):764-774.e1. doi: 10.1053/j.gastro.2022.06.023. Epub 2022 Jul 14.
6
Recent advances in lean NAFLD.非酒精性脂肪性肝病的最新进展。
Biomed Pharmacother. 2022 Sep;153:113331. doi: 10.1016/j.biopha.2022.113331. Epub 2022 Jun 29.
7
The Association between Non-Alcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis with Serological Vitamin B12 Markers: Results from the NHANES 1999-2004.非酒精性脂肪性肝病(NAFLD)与血清维生素 B12 标志物相关的肝纤维化程度的关联:来自 1999-2004 年 NHANES 的结果。
Nutrients. 2022 Mar 14;14(6):1224. doi: 10.3390/nu14061224.
8
Association of genetic variations with NAFLD in lean individuals.瘦人非酒精性脂肪性肝病相关的遗传变异。
Liver Int. 2022 Jan;42(1):149-160. doi: 10.1111/liv.15078. Epub 2021 Oct 12.
9
The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995-2040.日本非酒精性脂肪性肝病和瘦型非酒精性脂肪性肝病的流行病学:1995-2040 年的个体和预测分析荟萃分析。
Hepatol Int. 2021 Apr;15(2):366-379. doi: 10.1007/s12072-021-10143-4. Epub 2021 Feb 12.
10
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?非酒精性脂肪性肝病的白种瘦体型受试者与非瘦体型受试者具有相似的长期预后:是否需要重新评估 BMI 驱动方法?
Gut. 2022 Feb;71(2):382-390. doi: 10.1136/gutjnl-2020-322564. Epub 2021 Feb 4.